Summary
Samenvatting ziekteleer (Prof. Dierickx) (E0F10A)
- Course
- Institution
Volledige samenvatting ziekteleer van deel Prof Dierickx van schakelstudent seksuologie
[Show more]
Seller
Follow
friekemestdagh
Content preview
ZIEKTELEER (PROF.DIERICKX)
Academiejaar ’23 – ‘24
0
,INHOUDSOPGAVE
H1: KANKER ................................................................................................................................. 1
ALGEMEEN .......................................................................................................................................... 1
Definitie en kenmerken ................................................................................................................. 1
statistieken .................................................................................................................................. 2
Indeling ........................................................................................................................................ 2
diagnostisch pad .......................................................................................................................... 3
Symptomen.................................................................................................................................. 3
Lokale effecten (primaire tumor of metastasen) .......................................................................................... 3
lonkgkanker ........................................................................................................................................... 3
borstkanker ........................................................................................................................................... 4
Darmkanker ........................................................................................................................................... 4
huidkanker............................................................................................................................................. 4
centraal zenuwstelsel tumoren ............................................................................................................... 4
hematologische tumoren ....................................................................................................................... 5
metastasen ........................................................................................................................................... 5
niet-specifieke symptomen ........................................................................................................................ 5
metabole effecten...................................................................................................................................... 5
Tumor lysis syndroom ............................................................................................................................ 6
paraneoplastische symptomen .................................................................................................................. 6
Myasthenia gravis .................................................................................................................................. 6
alarmsymptomen ...................................................................................................................................... 7
Performantiestatus ....................................................................................................................... 7
Diagnose ...................................................................................................................................... 7
Bloedresultaten ......................................................................................................................................... 7
tumormerkers ........................................................................................................................................ 8
Histologische classificatie.......................................................................................................................... 8
Staging ...................................................................................................................................................... 8
lymfomen .............................................................................................................................................. 9
Solide (vaste) tumoren ........................................................................................................................... 9
Beeldvorming......................................................................................................................................... 9
OORZAKEN ........................................................................................................................................ 10
Medicatie ....................................................................................................................................10
biologische agentia ......................................................................................................................10
beroepsblootstelling/omgevingsfactoren ......................................................................................11
straling ........................................................................................................................................11
voeding .......................................................................................................................................11
middelen.....................................................................................................................................11
PREVENTIE......................................................................................................................................... 12
primaire preventie .......................................................................................................................12
secundaire preventie ...................................................................................................................12
Borstkanker ..............................................................................................................................................12
baarmoederhalskanker .............................................................................................................................13
colorectale kanker ....................................................................................................................................13
longkanker................................................................................................................................................13
prostaatkanker .........................................................................................................................................13
Melanoom ................................................................................................................................................14
BEHANDELING .................................................................................................................................... 14
chemotherapie ............................................................................................................................14
celcyclus ..................................................................................................................................................14
ontwikkeling .............................................................................................................................................14
, Toediening en dosis ..................................................................................................................................15
Principes ..................................................................................................................................................15
Nevenwerkingen .......................................................................................................................................15
chemotherapie geïnduceerde nausea en braken (CINV) ..........................................................................15
Myelotoxiciteit (beenmergtoxiciteit) .......................................................................................................16
diarree ..................................................................................................................................................16
constipatie ...........................................................................................................................................16
orale mucositis .....................................................................................................................................16
Andere orgaantoxiciteit .........................................................................................................................16
andere ..................................................................................................................................................17
heelkunde ...................................................................................................................................17
profylactische (preventieve) heelkunde ......................................................................................................17
diagnose en staging ..................................................................................................................................17
met curatief opzet .....................................................................................................................................17
Met palliatieve opzet .................................................................................................................................17
andere procedures....................................................................................................................................18
Radiotherapie ..............................................................................................................................18
Soorten behandeling .................................................................................................................................18
toediening ................................................................................................................................................18
nevenwerkingen ........................................................................................................................................19
H2: HEMATOLOGIE ...................................................................................................................... 20
BLOED .............................................................................................................................................. 20
structuur .....................................................................................................................................20
Plasma .....................................................................................................................................................20
Definities.....................................................................................................................................20
bloedcellen .................................................................................................................................21
rode bloedcellen (RBC) .............................................................................................................................21
witte bloedcellen (WBC) ............................................................................................................................21
Bloedplaatjes (BP).....................................................................................................................................22
afwijkingen ..................................................................................................................................22
Te weinig bloedcellen ................................................................................................................................22
Anemie .................................................................................................................................................22
leucopenie............................................................................................................................................23
thrombocytopenie ................................................................................................................................23
Te veel bloedcellen ...................................................................................................................................23
polycythemie ........................................................................................................................................23
leucocytose ..........................................................................................................................................23
thrombocytose .....................................................................................................................................24
Ziektebeelden ...........................................................................................................................................24
acute leukemie .....................................................................................................................................24
lymfoom ...............................................................................................................................................24
systeemziekten .....................................................................................................................................25
lupus ................................................................................................................................................25
systeemsclerose ...............................................................................................................................25
IMMUUNSYSTEEM ................................................................................................................................ 25
Lymfoïde organen ........................................................................................................................26
primaire/centrale ......................................................................................................................................26
Beenmerg .............................................................................................................................................26
thymus (zwezerik) .................................................................................................................................26
Secundaire/perifere ..................................................................................................................................26
tonsillen en Mucosa-associated lymphoid tissue (MAlt) ..........................................................................26
lymfeklier..............................................................................................................................................26
Milt .......................................................................................................................................................26
, Overzicht ..................................................................................................................................................27
Cellen .........................................................................................................................................27
Aspecifiek = Natuurlijke of aangeboren immuniteit .....................................................................................27
Specifieke = Verworven of adaptieve immuniteit .........................................................................................27
T-lymfocyten .........................................................................................................................................28
B-lymfocyten ........................................................................................................................................28
structuur van antistoffen ...................................................................................................................29
H3: CARDIOLOGIE ....................................................................................................................... 29
BLOEDSOMLOOP ................................................................................................................................. 30
BEVLOEIING ....................................................................................................................................... 30
HOLTES ............................................................................................................................................ 30
KLEPPEN .......................................................................................................................................... 31
WAND.............................................................................................................................................. 31
WERKING.......................................................................................................................................... 31
hartcyclus ...................................................................................................................................32
prikkelgeleiding ...........................................................................................................................32
elektrocardiogram (EKG) ...........................................................................................................................32
SYMPTOMEN ...................................................................................................................................... 33
ONDERZOEKEN ................................................................................................................................... 33
ZIEKTEN ............................................................................................................................................ 34
acuut myocardinfarct ..................................................................................................................34
toepassing: acuut coronair syndroom ........................................................................................................34
Hartfalen .....................................................................................................................................35
hartritmestoornissen ...................................................................................................................35
toepassingen ............................................................................................................................................35
ziekte van de hartkleppen.............................................................................................................36
endocarditis .............................................................................................................................................37
pericarditis ..................................................................................................................................37
Tamponnade ...............................................................................................................................37
aneurysma van de abdominale aorta ............................................................................................37
perifere arteriële insufficiëntie ......................................................................................................38
Cerebrovasculair accident (CVA) ..................................................................................................38
arteriële hypertensie ....................................................................................................................38
diepe veneuze thrombose ............................................................................................................39
longembool .................................................................................................................................39
H4: NEFROLOGIE ......................................................................................................................... 40
ANATOMIE ......................................................................................................................................... 41
onderdelen van het urinair stelsel .................................................................................................41
locatie nieren ..............................................................................................................................41
bouw van de nier .........................................................................................................................41
Bloedtoevoer naar de nieren ........................................................................................................41
Het nefron ...................................................................................................................................42
Glomerulus (vasculair) ..............................................................................................................................42
Tubulus (epitheliaal) .................................................................................................................................42
Werking van ADH op DTC en verzamelbuis .................................................................................................43
fysiologische processen ............................................................................................................................43
Bijnier .........................................................................................................................................43
Werking nieren ............................................................................................................................44
FUNCTIES NIEREN ............................................................................................................................... 45
,ONDERZOEKEN ................................................................................................................................... 45
urineonderzoek ...........................................................................................................................45
bloedonderzoek ..........................................................................................................................46
beeldvorming ..............................................................................................................................46
Andere onderzoeken ....................................................................................................................46
AANDOENINGEN ................................................................................................................................. 46
acute nierinsufficiëntie ................................................................................................................46
chronische nierinsufficiëntie ........................................................................................................47
nefrotisch syndroom ....................................................................................................................47
nierstenen ...................................................................................................................................48
pyelonefritis ................................................................................................................................48
, H1: KANKER
ALGEMEEN
DEFINITIE EN KENMERKEN
• Gekarakteriseerd door ongecontroleerde celdeling à groei van abnormaal weefsel
• Normaal vs kanker
Normaal Kanker
o Ontwikkeling en groei o Groei zonder de wetten van
o Volwassen weefsels het ecosysteem te
§ Homeostase behouden respecteren
– Stabiele toestand o Onaangepaste groei
– Herstel § Niet-adaptief:
§ Adaptief inspelen op wijzigende situaties zonder uitlokkende
– Hyperplasie = meer cellen aanmaken fysiologische
– Hypertrofie = grotere cellen aanmaken stimulus
– Flexibel en reversiebel § Niet flexibel of
reversibel: zonder
spontaan uitdoven
• Benigne vs maligne tumor
Benigne = goedaardig Maligne = kwaadaardig
Begrenzing Scherp Onregelmatig
Kapsel Frequent Zelden
Groeiwijze Niet-invasief Invasief
Groeisnelheid Laag Hoog
Necrose Zelden Frequent
Differentiatie Goed Slecht
Mitotische activiteit Laag Hoog
Metastasering Niet Wel
• Deling
1
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller friekemestdagh. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $11.32. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
73918 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now